These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18072717)

  • 1. The synthesis and chelation chemistry of DOTA-peptide conjugates.
    De León-Rodríguez LM; Kovacs Z
    Bioconjug Chem; 2008 Feb; 19(2):391-402. PubMed ID: 18072717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a DOTA--biotin conjugate for radionuclide chelation via Cu-free click chemistry.
    Schultz MK; Parameswarappa SG; Pigge FC
    Org Lett; 2010 May; 12(10):2398-401. PubMed ID: 20423109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonic-Assisted Solid-Phase Peptide Synthesis of DOTA-TATE and DOTA-
    Raheem SJ; Schmidt BW; Solomon VR; Salih AK; Price EW
    Bioconjug Chem; 2021 Jul; 32(7):1204-1213. PubMed ID: 32645261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.
    Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L
    Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
    Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
    Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOTA derivatives for site-specific biomolecule-modification via click chemistry: synthesis and comparison of reaction characteristics.
    Wängler C; Schäfer M; Schirrmacher R; Bartenstein P; Wängler B
    Bioorg Med Chem; 2011 Jun; 19(12):3864-74. PubMed ID: 21620712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomerism in benzyl-DOTA derived bifunctional chelators: implications for molecular imaging.
    Payne KM; Woods M
    Bioconjug Chem; 2015 Feb; 26(2):338-44. PubMed ID: 25635382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of DOTA-Metal Chelation Effects on the Chemical Shift of (129) Xe.
    Jeong K; Slack CC; Vassiliou CC; Dao P; Gomes MD; Kennedy DJ; Truxal AE; Sperling LJ; Francis MB; Wemmer DE; Pines A
    Chemphyschem; 2015 Dec; 16(17):3573-7. PubMed ID: 26376768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes.
    Sosabowski JK; Mather SJ
    Nat Protoc; 2006; 1(2):972-6. PubMed ID: 17406332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field.
    Reichert DE; Norrby PO; Welch MJ
    Inorg Chem; 2001 Sep; 40(20):5223-30. PubMed ID: 11559086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.
    Šimeček J; Hermann P; Havlíčková J; Herdtweck E; Kapp TG; Engelbogen N; Kessler H; Wester HJ; Notni J
    Chemistry; 2013 Jun; 19(24):7748-57. PubMed ID: 23613345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of oligonucleotides with DTPA and DOTA on solid phase.
    Hovinen J
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1459-62. PubMed ID: 18066806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional ligands based on the DOTA-monoamide cage.
    Barge A; Tei L; Upadhyaya D; Fedeli F; Beltrami L; Stefanìa R; Aime S; Cravotto G
    Org Biomol Chem; 2008 Apr; 6(7):1176-84. PubMed ID: 18362955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates.
    Liu S; Pietryka J; Ellars CE; Edwards DS
    Bioconjug Chem; 2002; 13(4):902-13. PubMed ID: 12121149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.
    Stasiuk GJ; Long NJ
    Chem Commun (Camb); 2013 Apr; 49(27):2732-46. PubMed ID: 23392443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation kinetics and stability studies on the lanthanide complexes of 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid by capillary electrophoresis.
    Zhu X; Lever SZ
    Electrophoresis; 2002 May; 23(9):1348-56. PubMed ID: 12007137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid phase synthesis of short peptide-based multimetal tags for biomolecule labeling.
    Brückner K; Zitterbart R; Seitz O; Beck S; Linscheid MW
    Bioconjug Chem; 2014 Jun; 25(6):1069-77. PubMed ID: 24830956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications.
    Dai L; Jones CM; Chan WTK; Pham TA; Ling X; Gale EM; Rotile NJ; Tai WC; Anderson CJ; Caravan P; Law GL
    Nat Commun; 2018 Feb; 9(1):857. PubMed ID: 29487362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4,7,10-triazacyclododecane-N,N',N″-triacetic acid as chelating agent for ¹¹¹In-labeled polypeptides.
    Suzuki H; Kanai A; Uehara T; Guerra Gomez FL; Hanaoka H; Arano Y
    Bioorg Med Chem; 2012 Jan; 20(2):978-84. PubMed ID: 22178661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy.
    Peterson JJ; Pak RH; Meares CF
    Bioconjug Chem; 1999; 10(2):316-20. PubMed ID: 10077483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.